Odyssey Health (ODYY) Non Operating Investment Income (2024 - 2025)
Odyssey Health (ODYY) posted Non Operating Investment Income of -$27364.0 for Q3 2025, up 55.4% on a QoQ basis from -$61357.0 in Q2 2025, and down 144.02% year-over-year from $62166.0 in Q3 2024.
Powered by 
Analysis
Odyssey Health (ODYY) Non Operating Investment Income (2024 - 2025) Analysis & Trends
Odyssey Health has reported Non Operating Investment Income for 2 years, with the latest figure at -$27364.0 in Q3 2025.
- On a quarterly basis, Non Operating Investment Income fell 144.02% year-over-year to -$27364.0 in Q3 2025; TTM through Apr 2026 was -$27364.0, a 92.6% increase from a year earlier, with the FY2025 full-year figure at -$459417.0, up 71.97% from the prior year.
- Non Operating Investment Income was -$27364.0 for Q3 2025 at Odyssey Health, up from -$61357.0 in the prior quarter.
- The five-year high for Non Operating Investment Income was $62166.0 in Q3 2024, with the low at -$1.3 million in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 178.50 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.21 Bn | 118.99 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | - |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.39 Bn | 65.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.69 Bn | 45.43 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.15 Bn | 20.67 Bn | 684.20 Mn | - |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2025 | -27,364.00 |
| Apr 30, 2025 | -61,357.00 |
| Oct 31, 2024 | -370,698.00 |
| Jul 31, 2024 | 62,166.00 |
| Apr 30, 2024 | -367,929.00 |
| Jan 31, 2024 | -1.33 Mn |